1 Min Read
Dec 28 (Reuters) - Provectus Biopharmaceuticals Inc
* Provectus Biopharmaceuticals terminates Peter Culpepper as interim CEO and COO Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.